4//SEC Filing
TAKANASHI KEN 4
Accession 0000950170-25-105353
CIK 0001631574other
Filed
Aug 6, 8:00 PM ET
Accepted
Aug 7, 8:00 PM ET
Size
5.0 KB
Accession
0000950170-25-105353
Insider Transaction Report
Form 4
TAKANASHI KEN
Director
Transactions
- Sale
Ordinary Shares
2025-08-05$8.75/sh−4,872$42,630→ 5,716,303 total
Footnotes (1)
- [F1]On August 5, 2025, the reporting person sold 4,872 ordinary shares solely to cover taxes associated with the vesting of restricted share units on August 5, 2025. These sales were made pursuant to a 10b5-1 Trading Plan.
Documents
Issuer
Wave Life Sciences Ltd.
CIK 0001631574
Entity typeother
Related Parties
1- filerCIK 0001657768
Filing Metadata
- Form type
- 4
- Filed
- Aug 6, 8:00 PM ET
- Accepted
- Aug 7, 8:00 PM ET
- Size
- 5.0 KB